ERAS-601

· Erasca, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ERAS-601, covering 2024-08-27 to 2026-04-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ERAS-601 in People With Chordoma [Phase 1, Phase 2]